Dr Aniket Nadkarni is an intensive care specialist at the Austin Hospital, Melbourne, and is a PhD candidate at Adelaide University, with a thesis titled "Mitigating the short and long term complications of stress-induced hyperglycaemia". His research interests including glycaemic control in the critically ill, neurocritical care, and iatrogenic anaemia.

Madeleine Hemphill is a Doctor of Medicine and Master of Philosophy student. Her research explores the markers, mechanisms and management of chronic complications in Type 1 Diabetes. She hopes to eventually specialise in interventional cardiology and integrate research with clinical practice to advance care for people with cardiovascular disease.

Dr Ruth Frampton is an Endocrinologist at Canberra Hospital and Health Services in Canberra, ACT, Australia, and a PhD candidate at the Garvan Institute of Medical Research, Sydney, NSW, Australia. Her primary research interest is cardiovascular and metabolic health in type 1 diabetes.

Tamara is an early career researcher. She was conferred her PhD from UNSW in February 2025. She is a Senior Research Associate in the Medicines Intelligence Research Program, School of Population Health, UNSW. She is also a clinician endocrinologist with appointments in St Vincent’s Clinic and Private Hospital and Randwick.

Xi May is a Staff Specialist Endocrinologist at Blacktown Hospital, and conjoint senior lecturer with Western Sydney University. She is a PhD candidate with the University of Sydney/Royal Prince Alfred Hospital, and has been awarded an NHMRC Postgraduate Scholarship.

Dr Borg is an endocrinologist and PhD candidate from South Australia. He graduated from the University of Adelaide with Honours in 2018 and completed clinical training in Adelaide. Alongside clinical practice, Dr Borg leads research into the application of gut-nutrient interactions for diabetes care.

Megan Dharma is an Endocrinologist currently completing her PhD candidature at The Royal Melbourne Hospital, Department of Diabetes and Endocrinology. Her thesis aims to investigate the variation in management across acute inpatient diabetes care and to explore technological solutions to improve identification, documentation and therapeutic management approaches.

Dr Yee Wen Kong is an endocrinologist with a strong interest in type 1 diabetes and diabetes technology research. She is pursuing a PhD, focusing on ketone monitoring technology and use to SGLT2 inhibitors in type 1 diabetes.